Wockhardt Q4 net profit at Rs 334.76 crore. Declares Rs 5/- per share dividend.

Drug firm Wockhardt on Monday reported a consolidated net profit of Rs 334.76 crore (Rs 3.34 billion) for the fourth quarter ended March 31, 2013, mainly on back of robust sales.

It had posted a net loss of Rs 191.64 crore (Rs 1.91 billion) for the corresponding period previous fiscal, the company said in a filing to BSE.

Consolidated net sales of the company stood at Rs 1,485.50 crore (Rs 14.85 billion) for the quarter under consideration as against Rs 1,175.60 crore (Rs 11.75 billion) for the same period a year ago.

In a separate filing to BSE, the company said its board has ‘recommended dividend at the rate of 0.01 per cent (Rs 0.0005 per preference share of Rs 5 each) absorbing a sum of Rs 2,98,557 on 475,659,941 non-convertible cumulative redeemable preference shares of Rs 5 each and 121,454,927 optionally convertible cumulative redeemable preference shares of Rs 5 each.’

The board recommended dividend of Rs 5 per equity share of Rs 5 each for the year 2012-2013, it added.

Consolidated net profit for the financial year ended March 31, 2013 stood at Rs 1,594.12 crore (Rs 15.94 billion) as against Rs 342.71 crore (Rs 3.42 billion) for the previous fiscal year.

Corresponding net sales of the company rose to Rs 5,609.42 crore (Rs 56.09 billion) for the fiscal year ended March 31, 2013 from Rs 4,350.50 crore (Rs 43.50 billion) for the earlier fiscal.

Shares of Wockhardt ended at Rs 1,278.25  on NSE, up 3.58 per cent from its previous close.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.